Organic anion-transporting polypeptide 2B1 knockout and humanized mice; insights into the handling of bilirubin and drugs

Wenlong Li(Tianjin University of Traditional Chinese Medicine), Alfred H. Schinkel(Oncode Institute), Rolf W. Sparidans(Slotervaartziekenhuis), Dirk R. de Waart, Els Wagenaar(The Netherlands Cancer Institute), Maria C. Lebre(The Netherlands Cancer Institute), Jos H. Beijnen(The Netherlands Cancer Institute), Margarida L.F. Martins(The Netherlands Cancer Institute), Yaogeng Wang(The Netherlands Cancer Institute), Dilek Iusuf(Utrecht University), Stéphanie van Hoppe(The Netherlands Cancer Institute), Olaf van Tellingen(Dutch Cancer Society)
Pharmacological Research
March 10, 2023
10.1016/j.phrs.2023.106724
Cited by 13

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
|PubMed|2002|688